A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Mcgill University Health Center
Montreal, Quebec, Canada
- Chu de Quebec - Universite Laval
Québec, Quebec, Canada
- Milton Keynes Hospital
Milton Keynes, Buckinghamshire, United Kingdom
- Hinchingbrooke Hospital
Huntingdon, Cambridgeshire, United Kingdom
- Royal Cornwall Hospital, Treliske
Truro, Cornwall, United Kingdom
- Royal Devon and Exeter Hospital
Exeter, Devon, United Kingdom
- Royal Sussex County Hospital
Brighton, East Sussex, United Kingdom
- Southend Hospital
Westcliff-on-Sea, Essex, United Kingdom
- Darent Valley Hospital
Dartford, Kent, United Kingdom
- Maidstone Hospital
Maidstone, Kent, United Kingdom
- Royal Liverpool University Hospital
Liverpool, Merseyside, United Kingdom
- James Paget University Hospital
Great Yarmouth, Norfolk, United Kingdom
- Musgrove Park Hospital
Taunton, Somerset, United Kingdom
- Weston General Hospital
Weston-super-Mare, Somerset, United Kingdom
- the Royal Marsden Hospital
Sutton, Surrey, United Kingdom
- Salisbury Hospital
Salisbury, Wiltshire, United Kingdom
- Kidderminster Hospital
Kidderminster, Worcestershire, United Kingdom
- Alexandra Hospital
Redditch, Worcestershire, United Kingdom
- Worcestershire Royal Hospital
Worcester, Worcestershire, United Kingdom
- Belfast City Hospital
Belfast, United Kingdom
- Royal Bournemouth Hospital
Bournemouth, United Kingdom
- Western General Hospital (edinburgh Cancer Centre)
Edinburgh, United Kingdom
- St James' University Hospital
Leeds, United Kingdom
- Barnet Hospital
London, United Kingdom
- Charing Cross Hospital
London, United Kingdom
- the Royal Marsden Hospital
London, United Kingdom
- University College London Hospitals
London, United Kingdom
- Whittington Hospital
London, United Kingdom
- Nottingham University Hospitals Nhs Trust, City Campus
Nottingham, United Kingdom
- Derriford Hospital
Plymouth, United Kingdom
- Singleton Hospital
Swansea, United Kingdom
- Long Beach Memorial Medical Center-Todd Cancer Institute
Long Beach, California, United States
- University of Miami Hospital and Clinics - Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Cancer Care Specialists of Central Illinois
Decatur, Illinois, United States
- Norton Cancer Institute - Brownsboro Medical Plaza I
Louisville, Kentucky, United States
- Norton Cancer Institute - Suburban, Norton Medical Plaza Ii
Louisville, Kentucky, United States
- Norton Healthcare Pavillion
Louisville, Kentucky, United States
- Metro-Minnesota Ccop
Saint Louis Park, Minnesota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2015
- Primary completion
- 31 Jul 2018
- Completion
- 31 Mar 2019
- Last update posted
- 13 Jan 2022
- Registered enrollment
- 307
- Registry id
- NCT02296801
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.